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Neuron-glia interactions establish functional membrane domains along myelinated 
axons. These include nodes of Ranvier, paranodal axoglial junctions and 
juxtaparanodes. Paranodal junctions are the largest vertebrate junctional adhesion 
complex, are essential for rapid saltatory conduction, and contribute to assembly and 
maintenance of nodes. However, the molecular mechanisms underlying paranodal 
junction assembly are poorly understood. Ankyrins are cytoskeletal scaffolds traditionally 
associated with Na+ channel clustering in neurons and important for membrane domain 
establishment and maintenance in many cell types. Here, we show that ankyrinB, 
expressed by Schwann cells, and ankyrinG, expressed by oligodendrocytes, are highly 
enriched at the glial side of paranodal junctions where they interact with the essential 
glial junctional component neurofascin 155. Conditional knockout of ankyrins in 
oligodendrocytes disrupts paranodal junction assembly and delays nerve conduction 
during early development. Thus, glial ankyrins function as major scaffolds that facilitate 






Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the 
central nervous system (CNS) wrap and insulate axons with myelin. They also actively 
cluster ion channels, cell adhesion molecules, and cytoskeletal scaffolds to form distinct 
functional domains along axons1, 2. For example, voltage-gated sodium (Nav) channels 
are highly enriched at nodes of Ranvier, while interactions between glial and axonal cell 
adhesion molecules (CAMs) flanking the nodes form paranodal junctions.  Together, 
myelin, clustered ion channels, and paranodal junctions make action potential 
propagation much faster and more efficient.  
Paranodal junctions perform several important tasks including: (1) restricting nodal 
proteins to assemble and maintain nodes; (2) separating juxtaparanodal voltage-gated 
K+ (Kv1) channels from nodal Nav channels; and (3) separating the periaxonal and 
extracellular spaces to fulfill myelin’s insulating role 3-7. An interacting set of CAMs, 
including axonal contactin and Caspr (contactin-associated protein) and glial NF155 (the 
155-kDa isoform of neurofascin), are highly enriched at paranodes and are vital 
constituents of the junctions1, 2. Loss of any single paranodal CAM disrupts paranodal 
junctions, and causes delayed nerve conduction, tremor, and ataxia8-10. Despite their 
importance, the mechanisms regulating clustering and maintenance of paranodal CAMs 
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remain unknown.   
Ankyrins have been implicated in formation and stabilization of membrane 
subdomains in many cell types11, 12. In the nervous system, ankyrinG (AnkG) is 
expressed by neurons and enriched at the axon initial segment (AIS) and node, where 
AnkG clusters Nav channels13-16. AnkyrinB (AnkB) is found in unmyelinated axons and 
regulates AIS assembly by establishing an intra-axonal boundary limiting the 
incorporation of AnkG into the distal axonal submembranous cytoskeleton17, 18. When 
axons are myelinated, in addition to nodal AnkG, AnkB and AnkG are detected at 
paranodes in the PNS and in the CNS, respectively 19-21. Given the important roles of 
ankyrins in axon domain organization, we sought to determine if ankyrins contribute to 
the assembly and function of paranodes. Surprisingly, in contrast to previous reports, we 
found paranodal AnkB and AnkG are not axonal, but glial paranodal scaffolding proteins 
that interact with NF155. Furthermore, conditional knockout of ankyrins in 
oligodendrocytes disrupted paranodal junction formation and delayed nerve conduction 
during early CNS development. These results reveal a mechanism where glial paranodal 





Paranodal AnkB is in Schwann cells 
The cytoskeletal scaffold AnkB is highly enriched at paranodal junctions in the PNS 
(Fig. 1a) and was previously reported to be in axons 19. To determine if AnkB is 
important for paranodal junction assembly, we silenced AnkB expression in cultured 
dorsal root ganglion (DRG) neurons by using a highly efficient shRNA (short hairpin 
RNA) and GFP (green fluorescent protein)-expressing construct delivered by 
adenovirus18. AnkB protein expression was efficiently eliminated from GFP-labeled 
axons (Fig. 1b). However, after axons were myelinated by co-culturing with Schwann 
cells, most of the GFP-labeled axons still showed clear paranodal AnkB that 
accumulated at the edges of the myelin sheaths (Fig. 1c). One explanation for the 
remaining paranodal AnkB immunoreactivity is that a very small amount of residual AnkB 
may be sufficient to form paranodal clusters. Alternatively, paranodal AnkB may be in 
Schwann cells and unaffected by the shRNA in neurons. In support of the latter 
possibility we found that: (1) in some myelinated axons paranodal AnkB was located 
outside and surrounding the GFP-labeled axons (Fig. 1d), and (2) immunoblots 
comparing purified cultured Schwann cells with cultured hippocampal neurons showed 
low levels of AnkB in cultured Schwann cells (Fig. 1e).  Furthermore, a transcriptome 
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analysis by Cahoy et al. reported a 2.1-fold increase in AnkB expression when 
comparing myelinating oligodendrocytes with oligodendrocyte precursors22, suggesting 
that myelinating glia express AnkB.  To clearly determine if paranodal AnkB is in axons 
or Schwann cells, we co-cultured AnkB-null23 DRG neurons and wild-type Schwann 
cells, then induced myelination. If paranodal AnkB is in Schwann cells, it should be 
detected in this culture combination. Consistently, in the absence of axonal AnkB, we still 
observed paranodal AnkB (Fig. 1f). Together, these results show that AnkB is a glial 
component of paranodal junctions. 
 
AnkB is not required for PNS paranodal junction assembly or function  
To study the role of paranodal AnkB in vivo, we removed AnkB specifically from 
myelinating glia by crossing Ank2-floxed mice with Cnp-Cre mice 24 (AnkB-cKO or 
Cnp-Cre;Ank2f/f; Fig. 1g); conventional AnkB knockout mice on a C57BL/6 background 
die at postnatal day (P) 0 before paranodal junctions form (data not shown). In 
AnkB-cKO sciatic nerves, AnkB staining was eliminated from paranodes (Fig. 1h,i 
arrows), consistent with the fact that paranodal AnkB is in Schwann cells and suggesting 
that neurons contribute no detectable AnkB to paranodal junctions. However, despite the 
strong enrichment of AnkB at paranodes in control mice, paranodal junctions, defined by 
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Caspr, NF155, and contactin, were assembled properly in AnkB-cKO mice (P28-P42 
shown in Fig. 1h,i and Fig. 2a,b).  In addition to their septate-like axoglial junctions, 
paranodes also have autotypic tight and adherens junctions between adjacent 
cytoplasmic loops2. In the AnkB-cKO mice, paranodal tight junctions (Fig. 2c), adherens 
junctions (data not shown) and the distribution of other paranodal loop components (Fig. 
2d-g) were all unaffected, indicating AnkB is not essential for the overall architecture of 
PNS paranodes.  
Paranodal junctions act as diffusion barriers that separate juxtaparanodal proteins 
from nodal proteins. Although the axonal paranodal scaffolds 4.1B and βII spectrin are 
not required for paranodal junction formation, they are crucial for barrier function25-27. To 
determine if paranodal AnkB plays a similar role in regulating juxtaparanodal protein 
localization from the glial side, we analyzed the distribution of Kv1.2 and Caspr2 in 
AnkB-cKO mice. We found that AnkB played no essential role in regulating 
juxtaparanodal protein localization (Fig. 2h,i).  Consistent with the normal localization 
of nodal, paranodal, and juxtaparanodal proteins we also measured no significant delay 
in nerve conduction velocities along the AnkB-cKO sciatic nerves compared to control 
nerves (Fig. 2j). 
We considered the possibility that loss of AnkB could delay paranode formation, or 
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result in eventual paranode degeneration and loss of polarized axon domains in aged 
mice.  However, we found that paranodal junctions formed normally in P3 sciatic nerves 
(Fig. 2k), and one-year-old AnkB-cKO mice had normal paranodes and juxtaparanodal 
clustering of Caspr2 (Fig. 2l). Finally, paranodal junctions have previously been 
implicated in switching of nodal Nav channel subtypes from Nav1.2 to Nav1.6 during 
development, since mice with disrupted paranodal junctions retain Nav1.2 at nodes6, 28. 
However, nodes in AnkB-cKO mice had Nav1.6 but no Nav1.2 (Fig. 2m), indicating that 
AnkB is not involved in the signaling pathway that regulates Nav channel subtype 
expression.  Together, these results demonstrate that AnkB is a glial paranodal protein, 
but surprisingly is not required for paranodal junction formation, function, or 
maintenance. 
 
AnkG is clustered at the glial side of CNS paranodes 
Immunostaining of the dorsal root entry zone from P31 mice showed that AnkG is 
enriched at nodes and CNS paranodes (Fig. 3a, arrow), while AnkB is found at PNS 
paranodes; we rarely observed AnkB at CNS paranodes (Fig. 3a)19. Although AnkG has 
been strongly implicated in Nav channel clustering at nodes14, 16, the role and cellular 
source of paranodal AnkG are unknown. Since paranodal AnkB is made by Schwann 
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cells in the PNS, and since AnkG is 5.7 times more enriched in oligodendrocytes 
compared to neurons and astrocytes22, we wondered if paranodal AnkG is also found in 
myelinating oligodendrocytes where it could contribute to paranodal junction assembly.  
To test this possibility, we constructed AnkG-deficient oligodendrocytes by crossing 
Ank3-floxed mice with Cnp-Cre mice (AnkG-cKO or Cnp-Cre;Ank3f/f; Fig. 3b).  Control 
mouse optic nerves showed both nodal and paranodal AnkG immunoreactivity (Fig. 
3c,d).  However, AnkG-cKO mice had only nodal AnkG (Fig. 3e), indicating that 
paranodal AnkG is found in oligodendrocytes. Thus, myelinating Schwann cells have 
paranodal AnkB, while myelinating oligodendrocytes have paranodal AnkG. 
 
AnkG is required for CNS paranodal junction assembly during early development  
To determine if paranodes require AnkG for normal function, we examined their 
assembly during myelination in AnkG-cKO mice.  Prior to the formation of full nodes 
(defined here as nodal clusters of βIV spectrin flanked by Caspr-labeled paranodal 
junctions on both sides), three kinds of nodal intermediates can be observed: 1) 
paranodes only, 2) nodes alone without flanking paranodal junctions, and 3) heminodes 
with paranodal junctions only on one side5, 20(Fig. 3h). We found in the optic nerves of 
P12 wild-type (WT) mice that the majority of nodal βIV spectrin clusters are flanked by 
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one or two Caspr-labeled paranodes (only 16.7±1.6% were lacking paranodal Caspr; 
Fig. 3f,h). In sharp contrast, the majority (53.5±0.9%) of nodal βIV spectrin clusters in 
AnkG-cKO optic nerves lacked flanking paranodal Caspr (Fig. 3g, arrows, and h). This 
defect in paranodal junction assembly was further reflected in a significant delay in the 
conduction velocity of compound action potentials (CAPs) in P17 AnkG-cKO optic 
nerves (Fig. 3i,j).  Thus, oligodendrocyte AnkG is required for normal paranodal 
junction assembly and function.  
Although we found a severe defect in paranodal junction assembly in the AnkG-cKO 
at P12, many paranodal junctions were still observed (Fig. 3h). Since AnkG contributes 
to both assembly and maintenance of axon initial segments 29-32, we speculated that 
these AnkG-independent paranodal junctions might degenerate in older AnkG-cKO 
mice. However, a detailed analysis of nodes and nodal intermediates in P12-P56 
AnkG-cKO optic nerves revealed that the number of paranodal junctions actually 
approached WT levels by P56. Furthermore, we measured no delay in the CAP 
conduction velocity along P56 AnkG-cKO optic nerves compared to WT mice (data not 
shown), and juxtaparanodal clustering of Kv1 channels was normal in P22 (Fig. 4b) and 
1-year old AnkG-cKO mice (Fig. 4c).  Together, these results suggest that paranodal 
junctions are assembled less efficiently in the absence of paranodal AnkG, but that they 
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eventually recover and do not require AnkG for their maintenance. 
 
AnkB partially compensates for the loss of AnkG at CNS paranodes 
The gradual recovery of paranodal junction formation suggests that other 
mechanisms or molecules may compensate for the loss of AnkG. To determine if other 
ankyrins compensate, we examined the expression of the two other vertebrate ankyrins:  
AnkR and AnkB.  Although we observed no AnkR at paranodes (data not shown), we 
did find many more AnkB-enriched paranodes in the AnkG-cKO optic nerves (Fig. 4d,e), 
suggesting AnkB may substitute for AnkG and rescue paranodal junction assembly in 
AnkG-cKO mice.  To test this possibility, we constructed AnkB/AnkG double cKO mice 
(AnkB/G-cKO) using Cnp-Cre to remove AnkB and AnkG from oligodendrocytes. 
AnkB-cKO mice showed virtually no defects in paranodal junctions in the CNS (Fig. 
4a,f). In contrast, when compared to AnkG-cKO mice, AnkB/G-cKO mice showed more 
severe defects in paranodal junction assembly throughout development, (Fig. 4a,g), and 
they also had slower nerve conduction velocities (Fig. 3j).  Thus, AnkB can partially 
compensate for the loss of AnkG in oligodendrocytes. Nevertheless, paranodal junctions 
still formed in the AnkB/G-cKO mice, and the differences between the AnkB/G-cKO, 
AnkG-cKO, and WT mice became smaller with increasing age (Fig. 4a).  
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Since myelination is a prerequisite for formation of nodes and paranodal junctions, 
one possible explanation for the paranodal changes described here is that myelination is 
delayed in the absence of glial ankyrins, and defective paranodal junction formation is 
secondary to delayed myelination. Importantly, we found that the density of nodal βIV 
spectrin clusters was similar among the WT, AnkG-cKO, AnkB-cKO, and AnkB/G-cKO 
mice (data not shown). Furthermore, electron microscopy of P17 WT and AnkB/G-cKO 
optic nerves showed no difference in the number or percentage of myelinated axons 
(Fig. 4j-l). These results indicate that myelination and paranodal junction assembly 
proceeds in the absence of paranodal ankyrins, but proper paranode formation occurs at 
a much reduced rate. 
 
AnkB and AnkG interact with NF155  
To understand the molecular mechanism whereby AnkG and AnkB regulate rapid 
paranodal junction assembly, we sought to identify their paranodal membrane protein 
binding partner. One possibility is that paranodal ankyrins function in concert with 
NF155, since NF155 is an essential component of paranodal junctions, and ankyrins 
bind to the cytoplasmic domain of neurofascins 33, 34. To test this possibility, we closely 
examined NF155 and AnkB localization in developing sciatic nerves. We found that 
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NF155 tended to be more enriched in subregions of paranodes where AnkB was located 
(Fig. 5a,b).  Furthermore, when AnkB extended beyond Caspr, NF155 extended 
together with AnkB (Fig. 5c,d), suggesting that during early development NF155 
localization is more closely aligned with AnkB than with Caspr.  Although paranodal 
NF155 was previously reported to be phosphorylated35 (which should block its 
interaction with ankyrins33, 34), immunoreprecipitation of AnkB from sciatic nerve and 
AnkG from spinal cord, in the presence of phosphatase inhibitors, co-precipitated NF155 
(Fig. 5e,f). Taken together, these results suggest that some paranodal NF155 is not 
phosphorylated and interacts with paranodal ankyrins in vivo. 
We previously proposed that during myelination, the initial interaction between glial 
NF155 and axonal Caspr/contactin assembles a paranodal lipid microdomain that 
promotes recruitment and stabilization of additional NF155 and Caspr/contactin 
molecules36. To determine if ankyrins contribute to these early events, we asked if they 
are recruited by NF155 to paranodal junctions. In Caspr-KO mice, paranodal junctions 
do not form and most paranodes have no detectable NF155 or AnkB (Fig. 5g, h)8. 
However, at some paranodes, low levels of colocalized AnkB and NF155 could still be 
detected (Fig. 5i, arrows). A similar but more prevalent phenomenon of paranodal, 
colocalized AnkG and NF155 was also seen in the Caspr-KO spinal cord (Fig. 5j, and k, 
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arrows).  These observations suggest targeting of AnkB and AnkG to paranodes does 
not require intact paranodal junctions, and argues against the idea that ankyrins are 
passively recruited by NF155/Caspr/contactin junctional complexes.  In further support 
of this idea, we analyzed sciatic nerve paranodal junctions from Nfasc-KO mice 
transgenically rescued using an NF155 construct that lacks its intracellular 
ankyrin-binding motif (NF155ΔIC)37. In some cases paranodal AnkB could be clearly 
observed (Figs. 5l-n, arrows). These observations suggest that ankyrins can be targeted 
to paranodes independently of NF155. 
 
Schwann cells and oligodendrocytes express 220-kDa AnkB from multiple 
promoters 
Previous studies have reported a variety of different ankyrin splice variants in the 
nervous system.  For example, neurons express both 270- and 480-kDa isoforms of 
AnkG at the AIS and nodes13, and 440-kDa AnkB is expressed in unmyelinated axons17, 
38. To determine if distinct isoforms of AnkB and AnkG are utilized by glia at paranodal 
junctions and how different cell types regulate expression of AnkB and AnkG, we 
designed isoform-specific primers and performed quantitative reverse 
transcription-polymerase chain reaction (qRT-PCR) analysis on P31 sciatic nerves and 
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spinal cords to detect the levels of various transcripts of AnkB and AnkG, respectively.  
Alternative splicing of the 6.2-kb giant exon of Ank2 (exon 40) can produce two AnkB 
isoforms: a 220-kDa AnkB produced by exclusion of exon 40, and a 440-kDa giant AnkB 
by inclusion of exon 4011 (Fig. 6e). Exon 24 is removed by our conditional knockout 
strategy (Fig. 1g), and we detected a graded reduction in the exon 24-containing 
transcripts in the AnkB-cHet and AnkB-cKO sciatic nerves and spinal cords (Fig. 6a, d). 
Similarly, we observed a graded decrease in the levels of the transcripts without exon 40 
(220 in Fig. 6a, d) but no significant decrease in the transcripts with exon 40 (440 in Fig. 
6a, d). Consistently, Western blotting of sciatic nerves and spinal cord homogenates 
showed a dramatic reduction of 220-kDa isoform of AnkB in the AnkB-cKO (Fig. 6b, c). 
These results suggest Schwann cells and oligodendrocytes express the 220-kDa AnkB.  
According to one previous study39 and the current Ensembl database, there are five 
alternative promoters available to express AnkB. We designated the first exons driven by 
these promoters as exon 1’’, exon 1’ (exon 0 in 39), exon 1, exon ‘1 and exon 1s from 
upstream to downstream (Fig. 6e; Supplementary Table 1).  To determine which first 
exon of AnkB is used by myelinating glia, we performed qRT-PCR to measure transcript 
levels; in our analysis we excluded exon 1s because antibodies specifically against 
AnkB’s spectrin-binding and C-terminal tail domain did not label paranodes in AnkB-cKO 
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mice (data not shown). We found that myelinating glia in sciatic nerves and spinal cords 
use multiple promoters: Schwann cells mainly express exons 1- and ‘1-containing 
transcripts, while oligodendrocytes express exons 1’ and ‘1-containing transcripts of 
AnkB (Fig. 6a, d). 
 
Oligodendrocytes express 190-kDa and 270-kDa AnkG isoforms by using the 
promoter at exon 1b 
AnkG also undergoes extensive alternative splicing11. Its splice variants include 
480-, 270-, and 190-kDa isoforms depending on whether and how the giant exon is 
incorporated (exon 41 in Fig. 7f). To reveal the isoforms expressed by oligodendrocytes, 
we performed qRT-PCR analysis of AnkG splicing on P31 spinal cords. Since exon 23 is 
removed by our conditional knockout strategy (Fig. 3b), we observed a graded decrease 
in exon 23-containing transcripts in the AnkG-cHet and AnkG-cKO (Fig. 7a). Among all 
the AnkG isoforms analyzed, the 190-kDa isoform-encoding transcripts showed the 
largest decrease, suggesting the majority of the 190-kDa isoform transcripts in P31 
spinal cords are expressed by oligodendrocytes. Although the AIS and nodal 480-kDa 
isoform remained unchanged in the AnkG-cHet and AnkG-cKO, surprisingly the 270-kDa 
isoform also exhibited a graded decrease similar to that detected in exon 23, suggesting 
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that it is expressed by both neurons and oligodendrocytes. Therefore, we examined the 
localization of the 270-kDa isoform using antibodies specific for 480/270-kDa AnkG13. 
Consistent with our qRT-PCR results, the anti-480/270-kDa AnkG antibody stained both 
nodes and paranodes in WT mice (Fig. 7c), but failed to stain paranodes in AnkG-cKO 
mice. Immunoblots of spinal cord homogenates also showed decreases in the 190- and 
270-kDa isoforms in the AnkG-cKO mice (Fig. 7b).  Thus, oligodendrocytes express 
both 190- and 270-kDa AnkG. 
Five alternative first exons have been identified for AnkG: 1a, 1b, 1e, 1f and 1s31, 40 
(1a, 1b, 1e and 1s correspond to I, III, 1 and 23, respectively in 41; Supplementary Table 
2). Because exon 1s is located between exons 25 and 26, exon 1s-containing AnkG 
should not be affected by our conditional knockout strategy (Fig. 7f and 3b). However, 
since our strategy eliminated paranodal AnkG, exon 1s-containing AnkG cannot be 
utilized by oligodendrocytes at paranodal junctions. To identify the AnkG promoter used 
by oligodendrocytes, we first stained spinal cord sections with antibodies against unique 
peptide sequences encoded by exons 1b and 1e31.  We found that nodal AnkG includes 
exon 1b- and 1e-containing AnkG proteins, whereas oligodendrocytes only have exon 
1b-containing AnkG at paranodes (Fig. 7d). To determine if exon 1a or 1f is also used by 
oligodendrocytes, we analyzed paranodal AnkG in the conventional KO of Ank3 exon 1b, 
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which is considered to be a cerebellum-specific KO31. Interestingly, paranodal AnkG was 
absent from the exon 1b KO (Fig. 7e), indicating that exon 1b is the main exon 1 utilized 
by oligodendrocytes and that the exon 1b KO is also a KO that affects oligodendrocytes. 
Consistent with these results, exon 1b-containing transcripts also showed a graded 
reduction in AnkG-cHet and AnkG-cKO mice (Fig. 7a). (The levels of exon 1e-containing 
transcripts decreased in the AnkG-cHet, but there was no significant further reduction 
detected in the AnkG-cKO suggesting this is likely an effect of heterozygosity in Cnp; the 
Cnp-Cre allele is simultaneously a Cre knock-in and Cnp KO allele24).  Thus, 
oligodendrocytes express 190-kDa and 270-kDa AnkG from the promoter at exon 1b. 
Our discovery of glial ankyrins and their alternative splicing compared to neuronal 
ankyrins reveal another level of complexity in neuron-glia interactions that parallels the 
situation for neurofascins: neurons express NF186 at the AIS and node, whereas 
myelinating glia express NF155 at paranodal junctions37, 42, 43.  Thus, the same genes, 






Ankyrins organize membrane subdomains in diverse cell types and regulate cell-cell 
interactions through these domains11, 12. The ankyrin and spectrin-based cytoskeleton 
also provides cells with membrane flexibility and toughness. For example, without 
functional AnkR, the plasma membranes of red blood cells become fragile, resulting in 
spherocytosis and anemia. In the nervous system, ankyrins and spectrins are 
reiteratively used to assemble polarized subdomains and support the delicate structure 
of axons and myelin18, 44-47.  Ankyrins were previously identified at paranodes19, 20, but 
their cellular source and functions remained unknown. Here, we showed that paranodal 
AnkB is produced by Schwann cells. However, this AnkB is dispensable for paranodal 
junction formation, function, and the organization of axonal membrane domains. In the 
CNS, AnkB is seldom observed at paranodes. Instead, AnkG is enriched at both 
paranodes in oligodendrocytes as well as in axons at nodes of Ranvier. Furthermore, the 
selective deletion of AnkG from myelinating glia caused a severe defect in paranodal 
junction formation during early development (Supplementary Fig. 1). 
Our data show that paranodal ankyrins interact with NF155 in vivo to regulate the 
early phase of CNS paranodal junction assembly. The interaction between neurofascin 
and ankyrins is required for aggregation of neuroblastoma cells mediated by homophilic 
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neurofascin interactions 34. Disruption of neurofascin’s cytoplasmic interaction with 
ankyrins increases its lateral mobility and severely compromises the ability of 
neurofascin-expressing cells to form large aggregates33, 34. Based on the multivalent 
binding property of ankyrins with more than one neurofascin molecule and two 
ankyrin-binding sites on one spectrin tetramer (which links the neurofascin-ankyrin 
protein complex to the actin cytoskeleton), we speculate that interactions between 
NF155 and ankyrins may stabilize many paranodal NF155 molecules in close proximity 
to one another to increase binding avidity for axonal Caspr/contactin. 
Why do paranodal ankyrins play more important roles in the CNS than the PNS? In 
the CNS, paranodal junctions function as lateral diffusion barriers and are the primary 
mechanism responsible for clustering of AnkG, Nav channels, and βIV spectrin at nodes 
of Ranvier5. In contrast, paranodal junction formation in the PNS follows clustering of 
nodal proteins and plays a secondary role to that of heminodal clustering by gliomedin4, 
48 (Supplementary Fig. 1b). This contrast may be partially explained by the observation 
that NF155 is expressed by oligodendrocytes before myelination, whereas Schwann 
cells express NF155 only after the onset of myelination and the initiation of nodal protein 
clustering36, 43, 49.  Similarly, paranodal clustering of ankyrins is detected during early 
myelination in the CNS20, but only after Caspr clustering in the PNS19. Our results also 
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suggest paranodal targeting of ankyrins does not require paranodal junctions or NF155. 
Based on these observations, we propose that during early CNS myelination, ankyrins 
facilitate the accumulation of NF155/Caspr/contactin clusters by actively targeting NF155 
to paranodes, or by clustering and stabilizing the earliest NF155/Caspr/contactin 
complexes at paranodes. Without paranodal ankyrins in the CNS, paranodal junction 
formation is severely delayed and preceded by nodal clustering, similar to the normal 
situation in the PNS (Supplementary Fig. 1b). To further understand the molecular 
mechanisms by which ankyrins facilitate paranodal junction assembly, it will be important 
to determine the paranodal targeting mechanisms for AnkB and AnkG. Intriguingly, 
myelin compaction seems to be a prerequisite for paranodal targeting of AnkG20.  
Although we observed a significant delay in CNS paranodal junction formation, our 
results show paranodal ankyrins are not absolutely required for junction assembly in the 
PNS or CNS. The eventual formation of paranodal junctions is not due to compensation 
by other ankyrins since neither AnkG nor AnkR compensate for the loss of AnkB in the 
PNS, and AnkR does not compensate for the loss of both AnkG and AnkB in the CNS 
(data not shown). We speculate that other unidentified glial paranodal junctional 
components may play a functional role redundant with that of ankyrins, or the clustering 
mechanism from the axonal paranodal cytoskeleton, including 4.1B, αII spectrin and βII 
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spectrin 1, 2, 19, may be sufficient to sustain paranodal junction assembly. However, 
paranodal junctions still form in 4.1B- and βII spectrin-KO mice25-27, 50, consistent with the 
idea of robust and redundant mechanisms for paranodal junction formation.  To test this 
possibility, it will be necessary to generate mice lacking both paranodal ankyrins and 
4.1B or βII spectrin to determine if they show more severe defects than single KO mice.  
Alternatively, the local environment at paranodal junctions may be sufficient to 
support the slow maturation of junctional NF155/Caspr/contactin complexes. Mature 
paranodal junctions have lipid raft-like properties 36, and paranodal proteins have 
features characteristic of proteins often found in lipid rafts51.  For example, contactin is a 
glycosylphosphatidylinositol (GPI)-anchored protein and neurofascin forms a dimer and 
is palmitoylated52, 53. We previously proposed that when NF155 and Caspr/contactin 
complexes bind to each other at paranodes, lipid-raft lipid components are also 
recruited.  The clustering of NF155/Caspr/contactin and lipid-raft lipid components 
mutually stabilize each other36. If this intrinsic mechanism is sufficient to constrain these 
CAMs within the special paranodal lipid environment, removal of glial cytoskeletal 
scaffolds may only cause a delay or mild defect in paranodal junction formation and no or 
mild defects in maintenance. Nevertheless, our results show that in the CNS, these 
ankyrin-independent mechanisms can only rescue late paranodal junction formation. 
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Although ankyrins are common to almost every cell in multicellular organisms and 
function as scaffolds, expression of ankyrins is remarkably complicated. First, ankyrins 
can be transcribed from several different alternative promoters, and different first exons 
encode their own stretches of peptide sequences. Second, ankyrin transcripts undergo 
extensive alternative splicing to produce various ankyrin protein isoforms11. AnkB and 
AnkG have alternative long exons whose incorporation makes giant versions of ankyrins. 
Giant AnkB and AnkG were thought to be exclusive to neurons11, 12. We consistently 
found myelinating glia utilize 220-kDa AnkB rather than its 440-kDa isoform. However, 
our analysis revealed that oligodendrocytes express both 190-kDa and 270-kDa AnkG. 
Why different ankyrin isoforms are expressed remains obscure since ankyrins generally 
function as scaffolds. However, one previous study showed that the protein domain 
specific to giant AnkG is required for its localization at the AIS54, suggesting one purpose 
of the different isoforms may be to locate scaffolds in different membrane subdomains 
and perhaps also provide functional regulation for their assembly and maintenance. 
Future studies will be required to determine the functions of different ankyrin isoforms in 
these diverse cellular compartments. 
AnkG has recently been implicated in psychiatric disorders including bipolar 
disorder, schizophrenia and autism by both association and sequencing studies55-60. In 
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addition to its crucial role at the AIS and nodes, our study reveals the importance of glial 
AnkG, and this pool of AnkG must be considered while the psychiatric etiology of the 
probable “AnkG syndromes” is pursued.  In spite of the severe delay in paranodal 
junction assembly and reduced conduction velocity in the AnkG-cKO and AnkB/G-cKO 
mice, we observed no tremor or ataxia and many paranodal junctions had already 
formed by P21 (Fig. 3j and 4a). However, a more detailed behavioral analysis may 
reveal how proper paranodal junction assembly affects activity-dependent circuit 
refinement during development, since the temporal pattern of neural activity should be 
altered by the reduced action potential conduction velocity in the AnkG-cKO and 
AnkB/G-cKO neonates. 
In conclusion, our study genetically defined paranodal ankyrins as ankyrins 
contributed by myelinating glia. Our data support a model where paranodal ankyrins 
facilitate clustering and stabilization of paranodal CAM complexes to potentiate early 






Animals. The AnkB conventional KO mice were described previously23 except that the 
genetic background was changed to C57BL/6. The Caspr KO61, AnkG exon 1b KO31, 
Neurofascin KO37, 62 and Cnp-Cre24 mice were described previously. Sprague-Dawley 
rats were purchased from Harlan Laboratories. Ank2floxed: exon 24 
(ENSMUSE00001285026 in Ensembl) is flanked by loxP sites (Peter, can you add 
details about the generation of the mice). Ank3floxed: exons 23 and 24 
(ENSMUSE00001261484 and ENSMUSE00001217354, respectively) are flanked by 
loxP sites63. 
 
Antibodies. The primary antibodies used were: rabbit antibodies against AnkB 
membrane-binding domain18, AnkB C-terminal region (H-300, SantaCruz), AnkG 
spectrin-binding domain and C-terminal region18, AnkG NT2 and NT3 were generated by 
immunizing against peptides unique to these domains followed by affinity purification of 
specific antibodies, AnkG 480/27013, GFP (A11122, Life Technologies), NF-M (AB1987, 
Millipore), Caspr36, βIV spectrin SD64, Kv1.265, Caspr2 (ab33994, Abcam), Nav1.266, 
4.1G67; mouse monoclonal antibodies against AnkB membrane-binding domain 
(N105/13 and N105/17, UC Davis/NIH NeuroMab Facility), AnkB spectrin-binding 
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domain (2.20, SantaCruz), AnkG spectrin-binding domain or C-terminal region (N106/36 
and N106/65, NeuroMab), Caspr (K65/35, NeuroMab), actin (C4, Millipore), ZO-1 
(ZO1-1A12, Life Technologies), E-cadherin (4A2C7, Life Technologies), Kv1.2 (K14/16, 
NeuroMab), Nav1.6 (K87A/10, NeuroMab), CNP (11-5B, Sigma-Aldrich), MAG (513, 
Millipore), Necl4 (N244/5, NeuroMab), pan-Nav channels (K58/3520) and GFP (N86/38, 
NeuroMab); the rat monoclonal antibody against MBP (MAB386, Millipore); chicken 
antibodies against NFasc (AF3235, R&D Systems) and βIV spectrin SD68; goat 
antibodies against contactin (AF904, R&D Systems) and AnkG (Vann, do you have a 
reference for this antibody?). The secondary antibodies were purchased from Life 
Technologies and Jackson ImmunoResearch. 
 
DRG neuron-Schwann cell myelinating co-culture. Primary DRG neuron culture and 
Schwann cell culture were prepared from Sprague-Dawley rats as described 
previously45. The purified rat DRG neurons were infected with the adenovirus carrying 
the construct expressing AnkB shRNA and GFP18 at 14 days in vitro (DIV). At 15 DIV, 
the whole culture medium was changed and the purified rat Schwann cells were added. 
Since 22 DIV, ascorbic acid had been included in the medium to induce myelination. The 
culture was fixed at 43 DIV (Fig. 1b, c) or 66 DIV (Fig. 1d) (21 or 44 days after induction 
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of myelination, respectively) and immunostained. The DRG neurons of the AnkB 
conventional KO were prepared from P0 neonates. The purified rat Schwann cells were 
added at 16 DIV; ascorbic acid had been included since 23 DIV. The co-culture was fixed 
and stained 28 days later (Fig. 1f). 
 
Immunostaining was performed as described previously5.  
 
Electrophysiology. Compound action potentials were measured in a bath of Locke’s 
solution with suction electrodes20 or in vivo69 as described. 
 
Transmission electron microscopy was performed in Integrated Microscopy Core at 
Baylor College of Medicine as described prerviously68. 
 
Immunoprecipitation. Adult rat sciatic nerves were homogenized in Homogenizing 
buffer (320 mM sucrose, 5 mM sodium phosphate pH 7.2, 0.2 mM NaF, 0.2 mM Na3VO4, 
2 × PhosSTOP (Roche), 2 µg/ml aprotinin, 1 µg/ml leupeptin, 2 µg/ml antipain, 10 µg/ml 
benzamidine and 0.5 mM PMSF) with sonication. The supernatant was collected after 
700 × g centrifugation for 10 min at 4˚C. P21 mouse spinal cords were homogenized in 
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Homogenizing buffer with Dounce homogenizer. The supernatant from 700 × g 
centrifugation (10 min at 4˚C) was centrifuged again at 27200 × g for 90 min at 4˚C. The 
pellet was resuspended in Homogenizing buffer. The lysates used for 
immunoprecipitation were prepared by diluting sciatic nerve and spinal cord 
homogenates to final protein concentration at 1 mg/ml with Lysis buffer (1% (v/v) Triton 
X-100, 20 mM Tris-HCl pH 8.0, 10 mM EDTA, 150 mM NaCl, 10 mM NaN3, 2 × 
PhosSTOP, 2 µg/ml aprotinin, 1 µg/ml leupeptin, 2 µg/ml antipain, 10 µg/ml benzamidine 
and 0.5 mM PMSF), supplementing Triton X-100 to totally 1%, mixing by a rotator for 1 
hr at 4˚C, centrifuging at 13000 × g for 30 min at 4˚C and harvesting the supernatants. 16 
µg of mouse monoclonal anti-AnkB N105/17 and anti-GFP N86/38 antibodies (for sciatic 
nerves) and 16 µg of mouse monoclonal anti-AnkG N106/36 and anti-GFP N86/38 
antibodies (for spinal cords) were each incubated with 40 µl of protein A agarose 
(Thermo Scientific) in 300 µl of Lysis buffer for 1-2 hr. The beads were washed with 1 ml 
of Lysis buffer three times and then incubated with the lysates (650 µl for sciatic nerves 
and 620 µl for spinal cords) overnight at 4˚C. The beads were then washed with 1 ml of 
ice-cold Lysis buffer four times and subjected to Western blotting. 
 
Quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Total 
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RNA of P31 spinal cords and sciatic nerves were prepared by homogenizing tissues in 
TRIzol reagent (Life Technologies) and then purifying RNA with Direct-zol RNA MiniPrep 
(Zymo Research). 1 µg (from spinal cords) and 0.5 µg (from sciatic nerves) of total RNA 
were used in 20 µl of reverse transcription reaction with SuperScript III First-Strand 
Synthesis System (Life Technologies) in the presence or absence of the reverse 
transcriptase according to the manufacturer’s instruction. The RT reaction was then 
diluted to 1/4 × and 2 µl were used for qPCR in 25 µl of reaction with Power SYBR Green 
PCR Master Mix and StepOnePlus Real-time PCR System (both from Life 
Technologies). The primers used in qPCR are as follows (sequences shown from 5′ to 
3′): AnkB exon 25 (forward: ACCACTACCACGACTATCAC; reverse: 
GTAGTTCATGCCATCCAGG), AnkB 440-kDa (forward: GGAACCCAAATCCACAAGAG 
; reverse: ACAGGAACTTCATTAACCAGG), AnkB 220-kDa (forward: 
CAACTTAAACATCACCCTGC ; reverse: AGTTCTCTTGCTAATTCTGTCC), AnkB exon 
1′′ (forward: ACCGAGGGAAGGAGTTC; reverse: GGAGAGCATTGAGTCCATTC), 
AnkB exon 1′ (forward: GCACATGGATTACAGTCTGAG; reverse: 
GCAGTTCTTCATGTCCCTG), AnkB exon 1 (forward: CTTCCCAAACTGTTCAAAATG; 
reverse: CCCCTTTCAGATATTCCACC), AnkB exon ′1 (forward: 
GGATGGAGCGGAAAAGAAA; reverse: CAGGTGGAGAGCATTGAG), AnkG exon 22 
30 
 
(forward: GTGAATGGGAACACAGCTC; reverse: TCATCGTTTCTGGGACATTC), AnkG 
exon 1a (forward: GCAGAGCCGAGTTCCTG; reverse: 
TGAATAACAGGATCCAAAGTCAC), AnkG exon 1e (forward: 
GTGAAGAGCCAAAGGAGAAG; reverse: TTGGAAGCAAGATGGAGTG), AnkG exon 
1b (forward: AAAAGGAAACACCGCAAACG; reverse: 
CTCAGAGACCACTTCCACATG), AnkG 480-kDa (forward: 
AGTAGGAGGACTGGTCCG; reverse: AGTTGTGGCATTCTTTCCG), AnkG 270-kDa 
(forward: GCCATGTCTCCAGATGTTG; reverse: TCTGTCCAACTAAGTCCCAG), AnkG 
190-kDa (forward: CTTTGCCTCCCTAGCTTTAC; reverse: the same as 270), and 
Polr2a (forward: CATCAAGAGAGTGCAGTTCG; reverse: 
CCATTAGTCCCCCAAGTTTG). Technical triplicates of each set of wild-type (WT), cHet 
and cKO tissues were performed and analyzed. Comparison of cHet with WT and cKO 
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Figure 1. Paranodal AnkB is derived from Schwann cells in the peripheral nervous 
system. (a) Immunostaining of a mouse sciatic nerve with antibodies against AnkG 
(green, node) and AnkB (red, paranodes). (b) Cultured DRG neurons were infected with 
adenovirus carrying a GFP and AnkB shRNA-expressing construct, and immunostained 
with antibodies against GFP (green) and AnkB (red). The GFP-positive axon is indicated 
by arrowheads. (c,d) Schwann cells were added to the same culture as in (b) and 
induced to myelinate. The co-culture was labeled for myelin basic protein (MBP, blue), 
GFP (green) and AnkB (red). The arrow points to paranodal AnkB (c). (e) Immunoblot of 
lysates from rat hippocampal neuron and purified Schwann cell cultures probed with 
anti-AnkB and anti-actin antibodies. (f) DRG neurons from the AnkB conventional KO 
were co-cultured with myelinating rat Schwann cells and labeled for AnkB (red), MBP 
(green) and neurofilament-M (NF-M, blue). The arrow points to paranodal accumulation 
of AnkB. Localization of AnkB along the inner mesaxon19 was also observed as spiral 
extensions from paranodal junctions. (g) The scheme of the Ank2 conditional allele. The 
two loxP sites (red triangles) flank exon 24. After Cre recombination and removal of exon 
24, a premature stop codon is generated in exon 25. (h,i) Immunostaining of sciatic 
nerve longitudinal sections from 4-week-old AnkB-cHet (h) and AnkB-cKO (i) with 
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antibodies against AnkB (red) and Caspr (green). Arrows point to paranodal junctions. 
Scale bars = 5 µm (a), and 10 µm (b-d,f), and 5 µm (h,i). 
 
Figure 2. No paranodal or axonal abnormalities were observed in sciatic nerves of 
AnkB-cKO mice. (a-i, k-m) Immunostaining of sciatic nerve longitudinal sections from 4 
to 6-week-old (a-I, m), P3 (k) and 1-year-old (l) mice shows normal paranodal and 
juxtaparanodal domains and proper Nav channel subtype switch in AnkB-cKO mice. 
NFasc, neurofascin (both nodal 186-kDa and paranodal 155-kDa isoforms were 
stained). Cntn, contactin. βIV, βIV spectrin. ZO-1, zona occludens protein 1. MAG, 
myelin-associated glycoprotein. CNP, 2',3'-cyclic nucleotide 3' phosphodiesterase. 
Necl4, nectin-like protein 4. (j) Conduction velocities of 6 P56 sciatic nerves from each 
genotype were measured using suction electrodes. ns, not significant. Scale bars = 5 µm 
(a,b), 5 µm (c-g), 5 µm (h), 5 µm (i), 5 µm (k), 5 µm (l), and 5 µm (m). 
 
Figure 3. Paranodal junction assembly is disrupted in AnkG-cKO mice. (a) The dorsal 
root entry zone from a P31 mouse spinal cord immunostained with antibodies against 
AnkB (green), AnkG (red) and βIV spectrin (βIV, cyan). PNS and CNS label the parts of 
the axon before and after its entry into the spinal cord, respectively. (b) The scheme of 
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the Ank3 conditional allele. The two loxP sites (red triangles) flank exons 23 and 24. 
After Cre recombination and removal of exons 23 and 24, a premature stop codon is 
generated in exon 25. (c-e) Immunostaining of P22 optic nerves with antibodies against 
AnkG (red) and βIV spectrin (green). Arrowheads point to paranodes. (f, g) 
Immunostaining of P12 optic nerves labeled for Caspr (green) and βIV spectrin (red). 
Arrows point to three nodal clusters of βIV spectrin without accompanying paranodal 
junctions. (h) Quantification of the percentages of full nodes and nodal intermediates 
(paranodes only, nodes alone and heminodes) in P12 optic nerves. (i,j) Conduction of 
compound action potentials along P17 optic nerves was measured using suction 
electrodes. The average peak velocities for each genotype is shown in (j). ns, not 
significant. **, p < 0.01. ***, p < 0.001. Scale bars = 5 µm (a), 3 µm (c-e), and 5 µm (f,g). 
 
Figure 4. Paranodal junctions recover over time in the CNS of the AnkG-cKO and 
AnkB/G-cKO mice. (a) Quantification of the percentages of full nodes and nodal 
intermediates (paranodes only, nodes alone and heminodes) in P12, P17, P21 and P56 
optic nerves. WT, wild type. G cKO, AnkG-cKO. B cKO, AnkB-cKO. B/G cKO, 
AnkB/G-cKO. The data for P12 WT and G cKO are the same as those shown in Fig. 3h. 
(b,c) Immunostaining of optic nerves from P22 (a) and 1-year-old (b) mice. (d,e) 
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Immunostaining of P22 optic nerves with anti-AnkB (red) and anti-Caspr (green) 
antibodies. (f,g) Immunostaining of P12 optic nerves with antibodies against Caspr 
(green) and βIV spectrin (red). (h,i) Immunostaining of P21 optic nerves with antibodies 
against NFasc (green), Kv1.2 channel (red) and βIV spectrin (blue). (j) Electron 
micrographs of P17 optic nerve cross sections. (k) Quantification of the percentage of 
axons in each diameter range that were myelinated. (l) Quantification of the percentage 
of total axons that belonged to different groups of diameter ranges. Scale bars = 3 µm 
(b), 3 µm (c), 5 µm (d,e), 5 µm (f,g), 5 µm (h,i), and 1 µm (j). 
 
Figure 5. AnkB and AnkG interact with NF155 in vivo and are targeted to paranodes 
independently of paranodal junctions and NF155. (a-d) P7 sciatic nerve sections stained 
for AnkB (red), NFasc (green) and Caspr (blue) (a,c), and the respective longitudinal line 
scans are shown (b,d). (e) Immunoprecipitation of AnkB from adult rat sciatic nerves 
co-precipitated NF155. Immunoprecipitation with the anti-GFP antibody served as a 
negative control. Heavy chain, mouse IgG heavy chain. (f) Immunoprecipitation of AnkG 
from P21 mouse spinal cords co-precipitated NF186 and NF155. (g-i) Immunostaining of 
P7 sciatic nerves with antibodies against AnkB (red) and NFasc (green). Arrows point to 
the residual AnkB and NFasc at paranodes. (j,k) Immunostaining of P7 spinal cords with 
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antibodies against AnkG (green) and NFasc (red). Arrows point to the residual AnkG and 
NFasc at paranodes. (l-n) Immunostaining of P5 sciatic nerves with antibodies against 
AnkB (red) and MAG (green). Arrows point to the paranodes with residual AnkB. Scale 
bars = (a,c) 5 µm for (a) and 3.3 µm for (c); 5 µm (g-i); 5 µm (j,k); 5 µm (l-n). 
 
Figure 6. Schwann cells and oligodendrocytes express 220-kDa isoform of AnkB from 
multiple promoters. (a) qRT-PCR analysis of P31 sciatic nerves shows the transcript 
levels relative to Ank2f/f after normalization to Polr2a as the internal control. N= 4 for all 
genotypes analyzed.  (b) Immunoblots of adult sciatic nerves homogenates probed with 
anti-AnkB and anti-actin antibodies. (c) qRT-PCR analysis of P31 spinal cords shows the 
transcript levels relative to Ank2f/f after normalization to Polr2a as the internal control. N= 
4 for all genotypes analyzed. (d) Western blotting of membrane homogenates from P42 
spinal cords probed with anti-AnkB and anti-actin antibodies. (e) The schema shows the 
alternative first exons from different promoters and alternative splicing of exon 40 of 
Ank2. 
 
Figure 7. Oligodendrocytes express the 270-kDa and 190-kDa isoforms of AnkG from 
the promoter upstream to exon 1b. (a) qRT-PCR analysis of P31 spinal cords shows the 
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transcript levels relative to Ank3f/f after normalization to Polr2a as the internal control. N= 
3 for all genotypes analyzed. (b) Immunoblotting of membrane homogenates from P31 
spinal cords probed with anti-AnkG and anti-neurofilament M (NF-M) antibodies. (c) 
Immunostaining of P22 spinal cords with antibodies against 480/270-kDa AnkG isoforms 
(green) and Caspr (red). (d) Immunostaining of P22 spinal cords with antibodies against 
the peptide sequence encoded by Ank3 exon 1e or 1b (green) and βIV spectrin (red). (e) 
P90 brain stems were labeled for AnkG (by N106/36, green) and Caspr (red). (f) The 
schema shows the alternative first exons from different promoters and alternative 
splicing of exon 41 of Ank3. Scale bars = 5 µm (c), 3 µm (d), and 2.5 µm (e). 
 
Supplementary Figure 1. (a) The molecular architecture of nodes of Ranvier and 
paranodes including membrane proteins and cytoskeletal scaffolds. Paranodal ankyrins 
are located in myelinating glia and interact with NF155. Schwann cells in the PNS 
express AnkB (B) whereas oligodendrocytes in the CNS mainly express AnkG (G). The 
shorter tail of paranodal AnkG symbolizes 190-kDa and 270-kDa isoforms and the longer 
tail of nodal AnkG designates 480-kDa and 270-kDa isoforms. Cntn, contactin. αII/βII, 
αII/βII spectrin tetramer. βIV, βIV spectrin. (b) The cartoon illustrates the differential 





Supplementary Table 1. The exon nomenclature of Ank2 used in this study. The exon 
information was collected from a previous study39 and the current information in the 
Ensembl database. The coordinates of each exon in chromosome 3 are shown. Except 
for the alternative first exons, all other known alternative exons are highlighted in yellow. 
Exons 2′ and 3′ are incorporated when exon 1′ is used. In this situation, exon 3′ is an 
alternative exon. When exon 1s is used, the predicted start codon is highlighted in red in 
exon 25. When exon 51 is included, the alternative stop codon is highlighted in red in 
exon 52.  
 
Supplementary Table 2. The exon nomenclature of Ank3 used in this study. The exon 
information was collected from a previous study40 and the current information in the 
Ensembl database. The coordinates of each exon in chromosome 10 are shown. Except 
for the alternative first exons, all other known alternative exons are highlighted in yellow. 
Exon 2a is incorporated when exon 1a is used.  
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exon 40: 440 kDa
skip exon 40: 220 kDa
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exon 41S: 270 kDa exon 41L: 480 kDa
skip exon 41: 190 kDa
42
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Phase Length Sequence 










2´ ENSMUSE00001226003 127,339,192 127,339,132 - 0 61 GTAAGTAACTGATCAGGGACATGAAGAACTGCTATTTCAAATGACAACCATGTTGCAAAAG 
3´ ENSMUSE00001237108 127,248,232 127,248,134 0 0 99 AGCCAAAACAAGTGTGAGAGCCAAACTACATGCAATGAAGTCACACAATCAAGCTGCATCCAACGCAAGGACCCCAATGGTGTGCATCCCGATGACCAG 
1 ENSMUSE00001216415 127,225,932 127,225,764 - 0 169 
GTCTCTTGTAAGTGCACGCACGCCAGTGGTCTGTTCCCGCGGCCGGGTTTGATGGCACAGCTATTTTCTTCCCAAACTGTTCAAAATGATGAACGAAGATGC
AGCTCAGAAAAGCGACAGTGGAGAGAAGTTTAATGGCAGTAGTCAAAGAAGAAAAAGACCCAAGAAG 








2 ENSMUSE00001276722 127,104,862 127,104,761 0 0 102 TCTGACAGCAATGCCAGCTTCCTCCGCGCTGCCAGAGCAGGCAACCTGGACAAAGTGGTGGAATATCTGAAAGGGGGCATTGACATCAATACCTGCAATCAG 
3 ENSMUSE00001294343 127,096,897 127,096,802 0 0 96 CAATGGAAGAGTAACCGATCCATGTGGACCAAGGAAACGAAGAGTCAGCTGGACGTGATAGTGCACGCCTTTAATCTCAGCATTTGGGAGACAGAG 
4 ENSMUSE00001224175 127,079,996 127,079,898 0 0 99 AATGGACTCAATGCTCTCCACCTGGCAGCCAAGGAAGGCCATGTGGGCCTTGTGCAGGAGCTGCTGGGAAGAGGGTCCTCCGTGGATTCTGCCACCAAG 
5 ENSMUSE00001293681 127,077,600 127,077,502 0 0 99 AAGGGAAATACCGCCCTTCACATTGCATCACTGGCTGGACAAGCAGAAGTTGTCAAAGTTCTAGTTAAGGAAGGAGCCAATATCAATGCCCAGTCGCAG 
6 ENSMUSE00001288369 127,057,091 127,056,993 0 0 99 AATGGCTTCACTCCTTTGTACATGGCTGCCCAGGAGAATCACATTGATGTTGTAAAATATTTGCTAGAAAATGGAGCTAACCAGAGTACTGCTACAGAG 
7 ENSMUSE00001297331 127,052,873 127,052,688 0 0 186 
GACGGCTTTACTCCTCTGGCTGTGGCACTCCAACAGGGACACAACCAGGCGGTGGCCATCCTCTTGGAGAATGACACCAAAGGAAAGGTGAGGCTACCAGCC
CTGCACATTGCTGCTCGGAAAGATGACACCAAGTCCGCCGCCCTCCTGCTTCAGAATGATCACAACGCTGATGTACAATCCAAG 
8 ENSMUSE00001306055 127,052,249 127,052,226 0 0 24 ATGATGGTGAACAGGACAACAGAG 
9 ENSMUSE00001295005 127,048,280 127,048,182 0 0 99 AGTGGCTTCACTCCTTTGCACATAGCTGCACACTATGGGAATGTAAATGTGGCAACTCTTCTTCTAAACCGGGGAGCTGCTGTGGACTTCACCGCCAGG 
10 ENSMUSE00001220180 127,046,823 127,046,725 0 0 99 AATGGAATCACTCCTCTGCACGTGGCTTCCAAACGAGGAAATACCAACATGGTGAAGCTTCTACTGGATCGAGGTGGTCAGATTGATGCCAAAACTAGG 
11 ENSMUSE00001234638 127,038,845 127,038,747 0 0 99 GACGGGCTGACACCACTTCACTGTGCTGCGCGGAGTGGGCATGATCAAGTGGTGGAGCTGCTGTTGGAACGGAAGGCTCCCTTGCTGGCGAGGACCAAG 
12 ENSMUSE00001252274 127,032,313 127,032,116 0 0 198 
AATGGGCTGTCCCCGCTTCACATGGCTGCGCAGGGGGACCACGTGGAATGTGTGAAGCACCTGCTCCAATACAAGGCGCCTGTCGATGACGTCACCCTGGAT
TACCTGACGGCTCTTCATGTTGCTGCACACTGTGGGCACTACCGTGTAACCAAACTCCTGCTGGACAAGAGAGCCAACCCGAACGCAAGAGCCCTG 
13 ENSMUSE00001235227 127,029,573 127,029,475 0 0 99 AATGGTTTTACTCCACTGCACATTGCCTGCAAGAAAAACCGCATCAAAGTCATGGAACTGCTGGTGAAATATGGGGCTTCAATCCAAGCTATAACAGAG 
14 ENSMUSE00001267026 127,029,317 127,029,219 0 0 99 TCTGGCCTCACACCAATACATGTGGCTGCCTTCATGGGCCACTTGAACATTGTCCTCCTTCTGCTGCAGAACGGAGCCTCTCCAGATGTCACTAACATT 
15 ENSMUSE00001300397 127,023,390 127,023,292 0 0 99 CGTGGTGAGACAGCTCTTCACATGGCGGCCCGGGCTGGGCAGGTGGAAGTGGTCCGATGTCTTCTGAGGAATGGTGCTCTTGTGGATGCCAGAGCCAGG 
16 ENSMUSE00001255725 127,017,013 127,016,816 0 0 198 
GAGGAGCAGACACCTTTACACATTGCCTCCAGGCTGGGGAAGACGGAAATTGTCCAGCTGCTTCTACAGCATATGGCTCACCCCGATGCAGCCACTACAAAT
GGGTACACACCACTACACATCTCTGCTCGGGAAGGACAGGTAGACGTGGCCTCTGTCCTGCTGGAAGCGGGAGCAGCCCATTCCTTAGCGACCAAG 
17 ENSMUSE00001261152 127,013,337 127,013,239 0 0 99 AAGGGCTTCACTCCCCTGCATGTAGCAGCCAAGTATGGAAGCCTGGATGTGGCAAAACTTCTCTTGCAACGTCGTGCAGCCGCAGATTCAGCAGGGAAG 
18 ENSMUSE00001233123 127,012,771 127,012,673 0 0 99 AATGGCCTTACCCCGCTCCATGTTGCTGCTCATTATGACAACCAGAAGGTGGCGCTGTTGCTGCTGGAGAAGGGTGCTTCCCCTCATGCCACGGCCAAG 
19 ENSMUSE00001263191 127,011,051 127,010,854 0 0 198 
AATGGCTATACTCCCTTACACATTGCTGCCAAGAAGAATCAGATGCAGATAGCTTCCACACTACTGAACTATGGGGCCGAGACTAACACTGTGACAAAGCAA
GGGGTCACTCCACTGCATCTGGCCTCACAAGAGGGGCACACAGACATGGTCACCTTGCTTCTGGACAAAGGAGCCAATATCCACATGTCAACCAAG 
20 ENSMUSE00001253269 127,004,043 127,003,945 0 0 99 AGTGGACTCACATCCTTACACCTTGCAGCCCAAGAAGATAAGGTGAACGTTGCGGACATTCTCACCAAACACGGGGCCGATCGGGATGCCTACACAAAG 
21 ENSMUSE00001233506 127,002,776 127,002,678 0 0 99 CTTGGTTACACACCTTTGATCGTGGCCTGTCACTATGGAAATGTGAAAATGGTCAACTTTCTTCTGAAACAGGGAGCAAATGTCAATGCGAAAACCAAG 
22 ENSMUSE00001232182 126,998,975 126,998,877 0 0 99 AATGGCTACACACCTTTGCACCAAGCTGCCCAGCAGGGCCACACACACATCATTAATGTCCTGCTCCAGCACGGGGCCAAGCCTAATGCTACTACTGCG 
1s ENSMUSE00000669796 126,998,461 126,998,324 - - 138 
AGTGTCCTGGGCTGGATGCAGCCAGAATTGCTAGCTTGTATAGTTTGTGCAGCACTGGAGATCCTGCAGCGCAGAAGCTAAATCTGTCACTGGGTCCCTATG
GTAACATCTTACCTGCAGCAGATGGCCTGACTCTTG 




24 ENSMUSE00001285026 126,988,216 126,988,144 0 - 1 73 
ACTATCACGGAAAAACATAAGCTAAATGTTCCTGAGACAATGACGGAGGTCCTTGATGTTTCTGATGAAGAGG 













27 ENSMUSE00001304535 126,976,154 126,976,051 0 2 104 
GTGTCTGCGCTAGCCAAGGAGGCAGAAAGGAATTCTTATCGTCTGAGCTGGGGCACTGAGAACTTAGACAACGTGGCTCTTTCTTCCAGTCCTATTCATTCA
GG 
28 ENSMUSE00001285906 126,971,038 126,971,003 2 2 36 CCGCTCCTCTCCATGTCTCGATCGTGACAACAGCAG 




30 ENSMUSE00001222661 126,963,481 126,963,383 2 2 99 TAAACTTCACCTGCCAACGGCTCCTCCCCCACTTAATGAGGGAGAAAGTTTGGTCAGCCGCATCCTTCAGCTGGGGCCTCCTGGAACCAAATTCCTTGG 
31 ENSMUSE00001233359 126,962,405 126,962,251 2 1 155 
GCCCGTGATCGTGGAGATCCCTCACTTCGCCGCTCTTCGAGGAAAGGAGAGGGAGCTGGTGGTCCTGCGCAGTGAAAATGGGGACAGCTGGAAAGAGCATTT
CTGCGACTACACTGAGGATGAATTGAACGAAATCCTTAATGGCATGGATGAAG 








34 ENSMUSE00001297707 126,957,352 126,957,256 1 2 97 GTGGAACTACGCCTGCCCAGTGGGAAGACATCACAGGAACAACGCCACTAACATTTGTCAATGAGTGTGTTTCCTTTACAACCAACGTGTCTGCCAG 




36 ENSMUSE00001233894 126,955,109 126,954,984 0 0 126 
GTATTGGAAGGAAAACCTATTTATGTTGATTGTTTTGGCAACCTGGTTCCACTAACCAAGAGTGGCCAACATCATATATTCAGCTTTTTTGCCTTCAAAGAA
AATAGACTTCCTCTCTTTGTCAAG 
37 ENSMUSE00001249776 126,953,299 126,953,177 0 0 123 
GTTCGTGACACAACCCAGGAACCTTGCGGGCGACTCTCATTTATGAAGGAACCCAAATCCACAAGAGGACTGGTGCATCAAGCTATTTGCAACTTAAACATC
ACCCTGCCAATTTATGCCAAG 
38 ENSMUSE00001281374 126,952,521 126,952,489 0 0 33 GAATCGGAGTCAGATCAAGAGCCGGAGGAAGAG 
39 ENSMUSE00000669794 126,950,756 126,950,735 0 1 22 ATCGGTATGACATCCGAAAAAA 






























































41 ENSMUSE00000563439 126,940,146 126,940,072 1 1 75 ATCCCCAAGATGAGCAGGAGCGGATGGAAGAAAGGCTGGCTTACATCGCTGATCACCTTGGCTTCAGCTGGACAG 
42 ENSMUSE00000563435 126,937,869 126,937,738 1 1 132 
AATTAGCAAGAGAACTGGATTTCACTGAGGAGCAAATTCACCAAATTCGAATCGAGAACCCCAACTCCCTTCAAGATCAGAGCCACGCACTGCTCAAGTACT
GGCTGGAGAGGGATGGGAAGCATGCCACAG 
43 ENSMUSE00000563434 126,936,763 126,936,620 1 1 144 
ATACCATCCTCATCGAATGCCTCACCAAGATCAACAGGATGGACATTGTACATCTCCTGGAGACCAACACAGAGCCCCTCCAGGAGCGCATGGGCCGCAGCT
ATGCAGAAATAGAGCAGACCATTACGCTGGACCACAGTGAAG 








46 ENSMUSE00001260738 126,930,653 126,930,561 0 0 93 GAGCTAACAGAGGAATTAGGAGAGCTGGAGGCTAGCTCTGATGAGGAGGCCATGGTAACTACCAGGGTTGTCCGCCGGAGAGTGATTATCCAG 
47 ENSMUSE00000563426 126,930,081 126,929,998 0 0 84 GGAGACGATATGCCTGACATACCCCCAGAGACGGTCACAGAGGAAGAATATGTTGATGAGAATGGACACACCGTGGTGAAGAAG 
48 ENSMUSE00001081872 126,929,886 126,929,722 0 0 165 
GTTACCCGGAAAATCATTAGGCGGTACGTTTCCTCTGATGGCACAGAGAAGGAGGAGGTTACCATGCAGGGAATGCCTCAGGAGCCAGTCAACATTGAGGAT
GGGGACAATTATTCCAAAGTGATAAAGCGCGTGGTATTGAAGAGTGACACCCAGCAGTCAGAG 
49 ENSMUSE00001077693 126,928,847 126,928,665 0 0 183 
GTGACTTTGTCTGAACCCAGCGTTTTGTCCAGTACCTCACAGTTTCAGGCCGAGCCAGTAGAAGGCCGTAGAGTCAGCAAAGTTGTTAAAACAACCATGGTA
CACGGAGAACGGATGGAGAAGAGTCTTGGGGACTCTAGCTTAGCCACTGACCTTCCTTCAGCCAAAGATGACTTTGAAGAG 
50 ENSMUSE00001303914 126,926,894 126,926,803 0 2 92 GCTTTGGGGTACACAGGTAGCCATATGAACGTCCACTTGCCCAGTTTAGTAGAGAATGAAATCCTGAAGGAGGATGGATCAATAATTAAGAG 































Phase Length Sequence 





2a n/a 69,484,229 69,484,267 0 0 39 GGTGACTTTGGATCCTGTTATTCACGAAGCTCTCAAAAG 













1f ENSMUSE00001263979 69,785,525 69,785,672 - 0 148 
AGGAGGTCGGGGAGACGTCTTTACGTTTTCCAAGGCGGATATTTTTAGACAGGATGTTCTGCCCCAAGTGTTAACTAATTGAGTTATCAGGTTTCGTATTTGGCC
TCAGAGAATGGCCGTGGAAGAGCCAGAGGGCTTCCCAGAAGAA 
2 ENSMUSE00001282033 69,808,416 69,808,517 0 0 102 TCTGATGCCAACGCAAGTTACTTAAGAGCAGCTCGGGCAGGGCACCTGGAAAAGGCCCTTGACTACATCAAAAATGGAGTGGACGTCAACATCTGTAACCAG 
3 ENSMUSE00001280093 69,808,873 69,808,971 0 0 99 AATGGATTGAATGCACTCCATCTTGCTTCCAAAGAAGGCCATGTGGAAGTGGTCTCTGAGCTGCTGCAGAGGGAAGCCAATGTTGATGCCGCCACAAAG 
4 ENSMUSE00001274976 69,809,171 69,809,269 0 0 99 AAAGGAAACACGGCCTTACACATCGCATCTTTGGCTGGGCAAGCGGAAGTGGTCAAGGTCTTGGTTACGAACGGAGCGAATGTCAACGCACAATCTCAG 
5 ENSMUSE00001241373 69,815,695 69,815,793 0 0 99 AATGGCTTCACACCATTGTATATGGCAGCCCAGGAGAACCACCTGGAAGTCGTCAGGTTTCTTCTGGACAATGGCGCCAGCCAAAGCCTGGCCACAGAG 
6 ENSMUSE00001288955 69,822,208 69,822,393 0 0 186 
GACGGCTTCACGCCATTGGCCGTGGCTCTGCAACAAGGTCATGACCAAGTCGTGTCCCTCCTGCTCGAGAACGACACGAAGGGAAAAGTGCGCCTCCCAGCCCTC
CACATCGCAGCCCGGAAAGACGACACCAAGGCAGCAGCTCTGCTCCTGCAGAATGACACAAACGCGGACGTGGAGTCAAAG 
7 ENSMUSE00001258555 69,823,078 69,823,101 0 0 24 ATGGTGGTGAATAGAGCAACTGAG 
8 ENSMUSE00001214460 69,824,318 69,824,416 0 0 99 AGTGGCTTCACCCCGCTCCACATAGCTGCCCACTATGGGAACATCAATGTGGCCACGTTGCTGTTAAACCGAGCGGCTGCTGTGGACTTCACCGCACGG 
9 ENSMUSE00001258730 69,850,106 69,850,204 0 0 99 AATGACATCACTCCCTTACACGTTGCCTCGAAGCGAGGAAATGCAAATATGGTGAAGCTATTGCTGGACCGGGGTGCGAAGATCGATGCCAAGACCAGG 
10 ENSMUSE00001250647 69,867,385 69,867,483 0 0 99 GACGGTCTGACTCCGTTGCACTGTGGGGCGAGAAGTGGCCATGAGCAGGTGGTAGAGATGTTGCTTGACAGATCCGCCCCCATCCTTTCAAAAACCAAG 
11 ENSMUSE00001297249 69,871,002 69,871,199 0 0 198 
AATGGATTGTCGCCACTGCACATGGCCACACAAGGAGACCATTTAAACTGCGTCCAACTCCTCCTCCAGCACAACGTGCCCGTGGACGACGTCACCAACGACTAC
CTGACTGCCCTCCATGTGGCTGCCCACTGCGGCCATTACAAAGTTGCCAAGGTTCTTTTGGATAAGAAAGCTAGCCCCAATGCCAAAGCCCTG 
12 ENSMUSE00001307807 69,874,790 69,874,888 0 0 99 AATGGCTTCACCCCTCTCCATATCGCCTGCAAAAAGAACCGCATCCGAGTAATGGAACTCCTTTTGAAGCACGGTGCATCTATTCAAGCCGTAACCGAG 
13 ENSMUSE00001272604 69,877,830 69,877,928 0 0 99 TCGGGCCTTACCCCAATCCATGTTGCTGCCTTCATGGGACATGTAAATATCGTGTCACAGCTAATGCATCATGGAGCCTCCCCAAACACCACCAATGTG 
14 ENSMUSE00001220057 69,879,893 69,879,991 0 0 99 AGAGGAGAGACGGCATTGCATATGGCGGCTCGGTCCGGACAAGCAGAAGTGGTGCGGTATCTGGTCCAAGATGGGGCTCAGGTAGAAGCAAAAGCTAAG 
15 ENSMUSE00001290652 69,882,361 69,882,558 0 0 198 
GATGACCAGACTCCACTCCACATCTCAGCCCGACTTGGGAAAGCTGACATAGTGCAACAACTGTTACAGCAAGGAGCATCCCCCAATGCAGCAACAACTTCTGGG
TACACCCCCCTTCACCTTGCGGCCAGAGAGGGGCATGAGGATGTAGCTGCGTTCCTCCTGGATCATGGAGCATCTTTATCCATAACAACAAAG 
16 ENSMUSE00001248451 69,884,747 69,884,845 0 0 99 AAGGGATTCACCCCTCTGCACGTGGCAGCCAAATACGGAAAGCTTGAAGTCGCAAGTCTCCTGCTGCAGAAGAGTGCGTCTCCCGATGCCGCAGGGAAG 
17 ENSMUSE00001279345 69,885,139 69,885,237 0 0 99 AGCGGGCTAACTCCACTGCATGTAGCAGCGCATTACGATAATCAGAAAGTGGCCCTTCTGCTCTTGGACCAGGGAGCCTCACCCCACGCAGCCGCAAAG 
18 ENSMUSE00001278922 69,892,322 69,892,519 0 0 198 
AATGGCTATACACCACTGCACATCGCGGCCAAGAAGAACCAGATGGACATAGCCACGTCCCTGCTGGAGTACGGTGCTGATGCAAACGCGGTTACCCGGCAAGGG
ATTGCGTCCGTCCATCTTGCGGCACAGGAAGGGCACGTGGACATGGTGTCGCTGCTCCTGAGTAGAAACGCGAATGTCAACCTGAGCAATAAG 
19 ENSMUSE00001280782 69,893,445 69,893,543 0 0 99 AGCGGTCTCACCCCACTCCACCTGGCTGCTCAAGAAGACCGAGTGAATGTGGCCGAGGTCCTTGTCAACCAGGGGGCCCATGTGGATGCTCAGACAAAG 
20 ENSMUSE00001220119 69,898,041 69,898,139 0 0 99 ATGGGCTACACCCCGCTCCATGTGGGCTGTCACTATGGAAATATCAAAATAGTCAATTTTCTGCTGCAGCATTCTGCAAAAGTTAATGCCAAGACGAAG 
21 ENSMUSE00001221633 69,898,228 69,898,326 0 0 99 AATGGATACACAGCACTGCACCAGGCTGCTCAGCAGGGCCACACGCATATCATCAATGTCTTGCTTCAGAACAACGCCTCCCCCAATGAACTCACTGTG 
22 ENSMUSE00001248586 69,898,994 69,899,089 0 0 96 AATGGGAACACAGCTCTGGCCATCGCCCGGCGCCTTGGTTACATCTCGGTGGTTGACACACTGAAGGTCGTGACGGAGGAAATTATGACCACCACT 
23 ENSMUSE00001261484 69,904,198 69,904,270 0 1 73 ACCATCACGGAGAAGCACAAAATGAATGTCCCAGAAACGATGAATGAAGTCCTCGATATGTCAGACGATGAAG 
24 ENSMUSE00001217354 69,904,448 69,904,510 1 1 63 TAAGGAAAGCCAGCGCCCCCGAAAAGCTCAGTGATGGGGAATATATCTCAGACGGTGAAGAAG 
25 ENSMUSE00001255465 69,920,438 69,920,491 1 1 54 GTGATAAATGCACATGGTTCAAAATTCCCAAAGTACAGGAGGTTTTGGTGAAAA 








26 ENSMUSE00001309139 69,927,695 69,927,818 1 2 124 
GTGAAGATGCCATCACAGGGGACACTGACAAGTATCTCGGGCCACAGGACCTTAAGGAGCTAGGTGATGACTCCCTGCCAGCAGAAGGTTACGTAGGCTTCAGTC
TTGGAGCCCGTTCTGCCAG 
27 ENSMUSE00001230155 69,929,447 69,929,458 2 2 12 TCCCAAGATAAG 
28 ENSMUSE00001286314 69,932,394 69,932,496 2 0 103 CCTCCGCTCCTTCAGTTCGGATAGGTCCTACACCTTGAACAGAAGCTCCTACGCAAGGGACAGCATGATGATAGAGGAACTTCTGGTACCATCCAAAGAGCAG 
29 ENSMUSE00001255995 69,950,952 69,951,058 0 2 107 
CACCTGACGTTCACGAGGGAGTTTGATTCTGACTCCCTCAGACACTACAGTTGGGCAGCGGACACGTTAGATAATGTGAACCTGGTCTCAAGCCCGGTGCATTCT
GG 
30 ENSMUSE00001220072 69,953,440 69,953,472 2 2 33 CTGCTCGTCTCCGCTGCCTCAGTATGACTCAAG 




32 ENSMUSE00001230547 69,958,918 69,959,072 2 1 155 
CCCCGTCATTGTGGAAATCCCTCATTTTGGGTCCATGAGGGGGAAGGAGAGAGAACTTATCGTCCTTCGGAGCGAGAACGGAGAGACCTGGAAGGAACATCAGTT
TGACAGTAAAAACGAAGACCTCGCGGAGCTTCTCAATGGCATGGATGAAG 




34 ENSMUSE00001268073 69,976,048 69,976,255 0 1 208 
GCTCAGCCCGTGCCAGAGGAAACGGTAAAAAAAATCCTTGGGAACAAAGCAACATTTAGCCCAATTGTCACGGTAGAGCCGAGGAGAAGGAAGTTCCATAAGCCG
ATCACCATGACCATTCCGGTGCCCCCGCCCTCGGGAGAAGGCGTGTCCAATGGGTACAAGGGGGATGCCACGCCCAACCTGCGGCTCCTCTGCAGCATCACAG 
35 ENSMUSE00001205997 69,977,713 69,977,809 1 2 97 GAGGCACCTCACCAGCTCAATGGGAAGACATCACAGGAACAACCCCTCTGACGTTCATAAAGGATTGTGTGTCTTTCACAACCAACGTTTCAGCCAG 




37 ENSMUSE00001292473 69,979,318 69,979,443 0 0 126 
GTTCTGGAAGGAAAGCCCATCTACGTTGATTGCTATGGAAACCTGGCCCCTCTGACCAAAGGAGGACAGCAGCTTGTTTTTAACTTTTATTCTTTCAAAGAAAAC
AGACTGCCATTTTCCATCAAG 
38 ENSMUSE00001279827 69,980,272 69,980,394 0 0 123 
ATCAGAGACACCAGTCAAGAGCCCTGTGGCCGCCTGTCTTTCCTGAAGGAGCCAAAGACAACAAAGGGATTACCCCAAACAGCTGTTTGCAACTTAAATATTACT
CTGCCGGCACATAAAAAG 




























































































42 ENSMUSE00001231047 69,994,372 69,994,446 1 1 75 GTCCGCAGAGTCCTTGTGAGCGGACGGATATCAGGATGGCGATAGTAGCCGATCACCTGGGACTTAGTTGGACAG 
43 ENSMUSE00001259541 69,998,095 69,998,226 1 1 132 
AGCTGGCAAGGGAACTGAATTTTTCAGTGGATGAAATCAACCAAATACGTGTGGAAAATCCCAATTCTTTAATTTCTCAGAGCTTCATGTTATTAAAAAAGTGGG
TGACCAGAGACGGAAAGAATGCCACAA 




































47 ENSMUSE00001243294 70,006,803 70,006,853 0 0 51 GTCAAAAGCCCGGGCGAAGCGTTTACGCGGATGACCGCCTGCTGTTACAAG 
48 ENSMUSE00001310630 70,008,778 70,008,864 0 0 87 GACTTGAGAAACAGTGAGAGTGATTCAAGCTCAGAGGAGGAGCAGAGGATCACTACCCGGGTCATACGAAGGCGTGTGATTATAAAG 
49 ENSMUSE00001226504 70,013,972 70,014,055 0 0 84 GGGGAGGAAGCCAAAAACATCCCTGGTGAATCTGTCACAGAAGAGCAATTTACTGATGAAGAAGGCAACCTCATCACGAGAAAA 
50 ENSMUSE00001227898 70,014,190 70,014,246 0 0 57 ATCACTCGGAAAGTAATAAGACGGATTGGTCCACAAGAGAGGAAGCAGGATGACGTG 
51 ENSMUSE00001313132 70,015,568 70,015,653 0 - 86 CAGGGAGAAGGCTATAAGGTGAAGACGAAGAAGGAAATCCGGAACGTGGAGAAGAAAACCCACTAGTGACAGTGACGTCAGTCCAG 
52 ENSMUSE00000612179 70,023,832 70,027,438 - - 3607 
GACCACTTGGTCATACTGCCAGTATTGAGAAACTCACCAGAGATCAGCAGGAAGAAAAATAGTCACCAAGAGTGGAGTGTGGGTCAGCTGCTTCCACCACACGTC
AGTGACACGATTTTTTTTTTGTAAACGCAGAAGGAAAACGAAAATCACATTTTTTCTTTCATTTAGCATGAGCCGATCTACAAAGCATGGAAACTCACATTCATT
CCCGGCACTGAAATGCACACTGAGCAAGTGCAGTGTACGACACAGGAAGCCATGTTCTTCAGACCCGGTCTCAAGTAATTTAGTGTCATTTTCAAAGAAGACAGA
CAAAACAACACCTGTGCCACCCAGGAGGAGGGGCAGCAGAGGACGGAATGATCAAATCAAGAAGACACACTAAAATTACTAAATTCACAACAGCTCGCCTTATTT
TTCTCGGACCCAAACTAACTGTCAGGGTATAAACACTGTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTTTTTTTAAAGAAAAATAATAATAATAATAATGAA
AAAAATCAATAGTTTTGCTGTAAATAATAACACTGTAAATTCTAACAGAAGAAACTACAATAAAGAATTATAAGGCACCCGCCTCACAGAACACAAAGATATCAC
AAATGCATCCAAGGACAGGCGTCCCAAGTGACTTCACCCTGGACAAGGATGGGGATCCAGCGCTCTCGGGACTCTTTCACTGACTCTTGTATATTAGCAATTATG
TTTGTACACGCAAAACTGCTAGCTTGATTTTAAAAGAAAAAAAATGCAAATCTTTAAAAAGGAAAAAAAAAAAAAAACCTGCTGCAAATTTAAATAATTCCCCAA
ACGAGGAATTCTGTAGTTCTGTGAAAAAAAATTTTTTTTTCTTCAGAATATTAATATTTTGATGCATGCATATCACCTTATTTTGATTAAATCTTTTCCAATTTT
GCAAACACTACAGTCTCCTGCAACATGGGAGATTTTATCTGTAAACACAAAGCCCTTCATCTAATATTTATTGCTATTGCCAATTTTTCAATGAAATGACCAAAA
ATGGAAAAAAAAATAACTATACAGTAGTTTGCTTGGGGGTGGGGGGAGGGGCGCTGTTAGTGCTTACAGGGGGGAAATGCTTGCCACTGTAGAAGTGGATGGTGC
TCACAAGAGGCCCCAGTCGTGGGTATTTAAAAAAATGGACTGACCGGAAATCCGTATCTAGCAGGATCGAAGCGCACTGTAAAAAAAAAAAAAAAGACAAAAAAA
AAAAAAAAAAAGATCGCTGTATTGTGTACTGGCTCTGAGATGTAGACCCCTTTCAGCAAGCCAATCACTAGTAACCATCCCAGCAGTGCCCCCATTAGGTTAGCG
GGGCTGCCGCGTTTTATAGAGCATTTTTCTTTGGGTTTGGTGAGGTTCCTTCATTCACTATCTTAACTTGAAATCGACCTCCACGGACACCTAGCTCTAAATGAC
ATGTATGAGAAAAGCAGACGCCGGATAAGCTAGTCGATTATTTAAGCATATAAAATAAACTGTGTTCAACTCTTCACCTACTTGGGTTCCACAGTGTTCTTGTAT
CCTCTGGCAAAACCTAGCTGTCTAATCCCCAGTCACAGGGGCCCTGTCTGTGCCTCCAGTCACTAAAGCCATACTCTGGAACGTTCTGCTCTCTCCCGAAAACAC
CCACCTTGCATAAACTCTGTGCACTTTGTGGGGGAGCTAAGAATTTAAAGATGAAGTAATCTTCGTCTATTTAGGCTCTTCTGCCCCATAGAAGAAGATGGGATT
TATAAGGCCAGTGTGTCAAGAAGTTATGCTGTTCCCAGGGAGCATCTATCTGTGGTTGATTTTTTTTTTTTTTTTTACCCCCCAGGAAGCATTGGTTTAGGTTTT
GTGTCATTAGTTTGCGGGCTTGGAGATTTTGTCATCACTGTTCTTGAGACAAGGTCTCAAAATGTCTGCTTAGTTTCTTAACTGATATGTTGTCAGAGCTTACAG
ATTGAGAAATTTTGCTAATAACTCGAGATTTTTTTATTTTACCAGTTTATTTTGGTACTGGTCATCATGCATGCTAAAAGATGTGAACTACCACTAAGCAGCACC
CTCGGCCTTCCCTGGATATTTCTGAGACGGCCTCACTAGCTGGTCCAAGCTGGCCTTGACTTTCCGAGGCTTCTGCCCTGTTTACTTAAGAGGGCTGCGCCACCA
GACTGAACAGGGGTTCTCTTGTGAAGCAACCTCCGGCAACAGCAGACCGCCCACTCCAAAAGACGTTGTAGGTGTGACCCCTACTCTCTCCAGCTACATTTGTGA
TCCCCGTCATCCTAGCCTTATTTCCTACCTAACCCTGAGAGGCACTTGGAGTTTGGGGCCCACTGATTTCATAACTCAAAGAGTTCAAAGATCTCATGCCTTTGA
TTCAACTTTTACCCCGGCCCACAGCCAGGCATGGCACATTAGGGGTGGTATCTCTCACCATCCTAAACTTCAAGTCCACACTATAACATTTTTCTTCTAAATACA
TTCCATTCATTGACTCGGTCCTTACCACCACTGTGTGAGTTAGATACTATCTTTGATGTAACAGGCCCCATATAGTATTAATGAATGCTTAATGTCATTCAAGGC
TGTTATTGCCTGTCCTATGGGATGAATATTCTCCAGAATTCCAGCCAGAAGACAAGTACCAGAGAGCCTATTTGGTCTAGAGAAGCCGCTTTCAATAAACAAAGA
GGCAGAGAGTACATTTGCATGTCATTTGCATGATGTCTGTGTCTACACCCCCAACCCCTGCCAATCAGAAACATCTAAACGACAAGCTGCCACACCTGAAAGTTT
TTTTAAAAGTCCCCAAAGCTTCTACATAACTAATAACAGAATATAAGAATGTTAACATCTCATTTAAGAGCTATGAATTCCAGACCCTCTGGCGTTGCTAGAGAT
TATTCAGATTTAGAAACTTAATGGGGTTATGTTACATGCCTGGAAATGTGACTTCAGGAACAGGTTGAGAGGTTCAGATGACACCAAAGCCATGAGTTGACCCAG
AAGTCTCTGAAGTACGATAGATTTTATTTACGCCTCTAACTTCTGTATATACTGCACCGAAATGGGACATAATGTTTGTATTTCCCTGTCAGCTCACTTAAATGT
ATTAAGATTTTTCTTTGACATTTTTGTAAAGAGAGAGAGAGAGAGAGAAAGAAAGAAAGAACTGTGACTGATAAAATCCTGAGATTTGCCACTTCTCCTTTATAC
ATTTTTACCCATTTGTTAACATGAAAGGGTTGTTTCTAGAAGGGACTCTCTTCACTGGCCACTCAAGCAACAGAGCTGGCTCTCTCACACTGGTATCCCAGCATC
CCACCATGTTCTTCTTAGCCGTCACCTTGGGGCTCCATACAATGGAAGTTTCTCTCCATGGTTAATAAACGTCGATGGAAAAGTGGTTTGCTTGACTTTCTTCAA
AGCCTCCCGCTCACATTTGACCGTGAGGAGCCCAGAAAGAAGCCACAGGAACAGCAACTATAGAACTTCGTGCCTCATCCAGGGGCATCTGGGTATTTGTTGGCC
AGGCAACTGGCATATTAAAAGGTGTATCATTTCCTAA 
	  
